• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

An Allscripts Play for a Push Higher

Yesterday's action in the stock speaks volumes.
By TIMOTHY COLLINS
Jan 13, 2015 | 12:43 PM EST
Stocks quotes in this article: MDRX

As the JPMorgan Healthcare Conference rolls on this week, it is clear there will be volatility in the sector, although we seemed to kick it off a bit early with news hitting as early as Sunday night. As far as coverage goes, I highly recommend following TheStreet's Adam Feuerstein.

I normally don't play this sector, but thanks to a ping from a friend north of the border, the Allscripts Healthcare Solutions (MDRX) chart is really one to look at. There's been some bullish option activity on the call side around this one, but I'm looking at the price action as well. Not what has happened, but what didn't happen.

Yesterday, the stock had all the looks of breaking down. The price was under support, the Relative Strength Index (RSI) was pressing against 50, the Vortex Indicator crossed bearish and the stochastics had a bearish look to them as well. By all accounts, this thing should have died. Heck, even the five-day moving average was under the 13-day moving average after a recent bearish cross. The thing is, it didn't. The stock reversed off the breakdown levels and pushed back into the moving averages.

MDRX Chart
Source: StockCharts.com
View Chart » View in New Window »

Now, we jump into today and see the stock green. Of course, the strong broader market is some help, but I'm beginning to think the breakdown yesterday was a fake. While we still see some bearish indicators, the RSI bouncing off of 50 rather than falling through it speaks volumes. Add in the fact that the price is trying to get above short-term moving averages today, and we just might be set up for a nice little push higher.

The price trigger is the multiple resistance lines, both short term and long term, which coincide at $13. The short-term resistance only goes back a few weeks, while longer term, we are talking about way back to August. I could almost argue for a two-headed inverse head-and-shoulders pattern here if such a thing existed, but it might be simpler to call it a curvy "W." The price target is $15, ultimately, with some resistance expected around $14, so I would use that as a level to take some profits.

There are two approaches to a stop. The first is the conservative approach of using any close under $12.50. Given our fakeout yesterday, I'd prefer to give it some more room and use $12 as the stop area. The idea of using puts on a break below $12.50 could also work here. Ideally, we'll see the price push over $13 and the Vortex Indicator or stochastics turn higher, but I like my risk-reward as I see this as risking $1 to make $2 with solid odds once we push over $13. I'm not quite there yet, but I will set a buy-stop on this one a few pennies over $13.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Collins had no positions in the securities mentioned.

TAGS: Investing | U.S. Equity | Healthcare

More from Healthcare

Updating Pfizer's Technical Condition

Bruce Kamich
Apr 20, 2021 9:50 AM EDT

We're now expecting further strength.

2 Health-Related Stocks See Bits of Insider Interest

Bret Jensen
Apr 19, 2021 10:00 AM EDT

Large purchases of Cortexyme Inc. and NantHealth Inc. shares have been made by insiders recently.

UnitedHealth Group's Charts Look Strong

Bruce Kamich
Apr 16, 2021 11:35 AM EDT

Here's where traders should look to buy a pullback.

Cigna Has Made a Huge Upside Breakout

Bruce Kamich
Apr 16, 2021 10:55 AM EDT

Traders could go long CI at current levels, and we have two price objectives.

Jim Cramer: We've Got a Boom ... and a Bust

Jim Cramer
Apr 15, 2021 3:36 PM EDT

Let's look at this impossible move on the market -- and why health care could be coming off life support.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 04:17 PM EDT REAL MONEY

    Wednesday on Real Money Pro

    Get-rich quick schemes offer little more than pipe...
  • 11:09 AM EDT GARY BERMAN

    S&P Futures

    FIBOCALL: The S&P futures was off 1.5 %... ...
  • 07:47 AM EDT CHRIS VERSACE

    Positive News for a Cannabis Play

    Good news for this name in the Stocks Under $10 po...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login